Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Lawrence

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Microbiology|September 20, 2013
Precise dissection of an Escherichia coli O157:H7 outbreak by single nucleotide polymorphism analysisGeorge Turabelidze, Steven J Lawrence, Hongyu Gao, et al.
Vaccine|March 8, 2017
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodiesJanie Parrino, Shelly A McNeil, Steven J Lawrence, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 18, 2023
Understanding and Addressing Bias in Grading: Progress at Washington University School of MedicineEve R Colson, Maria Pérez, Stanley Chibueze, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|February 25, 2021
Washington University School of MedicineEve R Colson, Sabrina Nuñez, Thomas M De Fer, et al.
Medical Science Educator|February 15, 2021
Student Response Initiatives: A Case Study of COVID-19 at Washington UniversityChristopher J Chermside-Scabbo, Katherine Douglas, Cyrus Ghaznavi, et al.
Plos One|April 14, 2018
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trialEdgar Turner Overton, Steven J Lawrence, Eva Wagner, et al.
The Journal of Infectious Diseases|June 16, 2007
Antibody responses to vaccinia membrane proteins after smallpox vaccinationSteven J Lawrence, Kathleen R Lottenbach, Frances K Newman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2021
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled StudyRoy F Chemaly, Francisco M Marty, Cameron R Wolfe, et al.
Haematologica|July 23, 2016
Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamideScott R Goldsmith, Michael Slade, John F DiPersio, et al.
The Journal of Infectious Diseases|July 30, 2020
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus VaccineElke Jordan, Steven J Lawrence, Thomas P H Meyer, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Microbiology|September 20, 2013
Precise dissection of an Escherichia coli O157:H7 outbreak by single nucleotide polymorphism analysisGeorge Turabelidze, Steven J Lawrence, Hongyu Gao, et al.
Vaccine|March 8, 2017
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodiesJanie Parrino, Shelly A McNeil, Steven J Lawrence, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|April 18, 2023
Understanding and Addressing Bias in Grading: Progress at Washington University School of MedicineEve R Colson, Maria Pérez, Stanley Chibueze, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|February 25, 2021
Washington University School of MedicineEve R Colson, Sabrina Nuñez, Thomas M De Fer, et al.
Medical Science Educator|February 15, 2021
Student Response Initiatives: A Case Study of COVID-19 at Washington UniversityChristopher J Chermside-Scabbo, Katherine Douglas, Cyrus Ghaznavi, et al.
Plos One|April 14, 2018
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trialEdgar Turner Overton, Steven J Lawrence, Eva Wagner, et al.
The Journal of Infectious Diseases|June 16, 2007
Antibody responses to vaccinia membrane proteins after smallpox vaccinationSteven J Lawrence, Kathleen R Lottenbach, Frances K Newman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2021
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled StudyRoy F Chemaly, Francisco M Marty, Cameron R Wolfe, et al.
Haematologica|July 23, 2016
Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamideScott R Goldsmith, Michael Slade, John F DiPersio, et al.
The Journal of Infectious Diseases|July 30, 2020
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus VaccineElke Jordan, Steven J Lawrence, Thomas P H Meyer, et al.
Pageof 4